Justin Ryder, an obesity researcher at Lurie Childrens Hospital in Chicago
Tesamorelin increases IGF-1, which is exactly what we want for body composition and longevity, but it does require monitoring to ensure levels stay within optimal range
Patients choose Coachlight because they want expert guidance, structured care, and a program built around long-term success
Conclusion In conclusion, discontinuing semaglutide or tirzepatide therapy for weight reduction poses unique challenges that require careful consideration and management
Hence, we considered patients to be combination users if their GLP-1 receptor agonist and SGLT-2 inhibitor prescriptions overlapped each other during the follow-up period
But what does tapering actually mean, and does it make a meaningful difference